Cell Cryopreservation Market, by Product Type (Cryopreservative Medium, Freezers, and Others), by Application, by End User and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

The process of stabilizing biological materials at cryogenic temperatures (below -1500 degree C) is called cryopreservation. Cryopreservation is used for the preservation of microorganisms, tissue cells, established cell-lines, small multicellular organisms, and complex cellular structures such as embryos, nucleic acid, and proteins. Cryopreservation procedures use liquid nitrogen, liquid helium, argon, and oxygen as cryogenic elements. Various types of samples with varying sensitivity require different types of cryopreservation equipment such as cryopreservation freezers, liquid nitrogen vessels, cryogenic vaporizers, cryogenic incubators, liquid tracking equipment, and cell freezing container.

Market Dynamics

Increasing product launches by market players is a major factor driving the global cell cryopreservation market growth. For instance, in 2021, Irvine Scientific, a manufacturer of cell culture media, introduced Arctic Sperm Cryopreservation Medium to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.

Furthermore, decrease in fertility rate is expected to drive the market growth. According to the Journal of Human Reproductive Sciences, 2015, around 40-80% of females face possible infertility as a result of their cancer treatments that is, chemotherapy, radiation, and surgery.

Key features of the study:

• This report provides in-depth analysis of the global cell cryopreservation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global cell cryopreservation market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation:

• Global Cell Cryopreservation Market, By Product Type:
  • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
  • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
• Global Cell Cryopreservation Market, By Application:
  • Stem Cells
  • Oocytes and Embryos
  • Sperm, Semen, and Testicular Tissue
  • Hepatocytes
  • Others
• Global Cell Cryopreservation Market, By End User:
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Biobank
  • Others
• Global Cell Cryopreservation Market, By Region:
  • North America
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country/Region:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
    • By Application:
    • Stem Cells
    • Oocytes and Embryos
    • Sperm, Semen, and Testicular Tissue
    • Hepatocytes
    • Others
    • By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Biobank
    • Others
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • General Electric Company*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • AMS Biotechnology (Europe) Limited
  • Miltenyi Biotec GmbH
  • BioLifeSolutions Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • PromoCell GmbH
  • Corning Incorporated
  • Cooper Companies, Inc.
  • Planer PLC

"*" marked represents similar segmentation in other categories in the respective section.